Background/Aims: The apoptosis of activated hepatic stellate cells (HSCs) is the central event in the reversal of liver fibrosis. K63 de-ubiquitinated receptor-interacting protein (RIP)1 promotes apoptosis in tumor necrosis factor (TNF)-α signaling pathway. In the previous study, we have proved that indole-3-carbinol (I3C) could reverse different models of liver fibrosis in rats, but the mechanism is still unclear. Thus, the present research aimed to demonstrate the induction of I3C on apoptosis of HSCs and the underlying molecular mechanism. Methods: HSC-T6, an immortalized rat liver stellate cell line, was treated for 24 hours with 25, 50 and 100 μM of I3C. The apoptosis of HSC-T6 was analyzed by flow cytometric analysis, acridine orange staining and RT-PCR, respectively. K63 de-ubiquitination of RIP1 and the expression of ubiquitin ligases and deubiquitinases were analyzed by Co-IP assay and western blot. Knockdown of deubiquitinases was undertaken by small interfering RNA (siRNA). Results: The results of flow cytometric analysis indicated that the apoptotic rate of HSC-T6 was induced by I3C in a dose-dependent manner. Observation by acridine orange staining exhibited nuclear condensation and apoptotic bodies in I3C treated cells. Consistently, the expression ratio of Bax/bcl-2 was markedly increased by I3C. These results indicated that I3C could significantly induce apoptosis of HSC-T6 cells. Furthermore, Co-IP assay revealed K63 de-ubiquitination of RIP1 by I3C, associated with the induction of caspase 8. Although I3C had no effect on the expression of ubiquitin ligases cellular inhibitor of apoptosis 1/2 (cIAP1/2), the protein level of deubiquitinase cylindromatosis (CYLD) was significantly induced by I3C. Moreover, CYLD silencing reversed the pro-apoptosis induction effect of I3C and reduced the expression ratio of Bax/bcl-2 in HSC-T6 cells. Conclusion: These results demonstrated that I3C could induce apoptosis of HSC through RIP1 K63 de-ubiquitination by upregulating deubiquitinase CYLD.
Indole-3-Carbinol Induces Apoptosis of

Introduction
Liver fibrosis is a common excessive healing response to various chronic liver injury, such as viral hepatitis, alcoholic hepatitis, nonalcoholic steatohepatitis, autoimmune hepatitis, and metabolic disease [1] . It is characterized by deposition of extracellular matrix (ECM) with distortion of normal hepatic parenchyma, eventually leading to dense fibrosis, cirrhosis, and development of portal hypertension [2] . Hepatic stellate cells (HSCs) are the primary cellular source of matrix components, and play a vital role in the development and maintenance of liver fibrosis [3] [4] [5] [6] . In their quiescent state, HSCs store vitamin A and retinoid, but upon tissue damage, they become activated and undergo proliferation and secretion of ECM proteins such as collagen, glycoprotein, and proteoglycans leading to hepatic fibrosis [6] . It is well known that liver fibrosis is a reversible disease, with the apoptosis of activated HSCs being the central event in this reversal [7] . Therefore, induction the apoptosis of HSC is a potential direction for the treatment of live fibrosis.
Tumor necrosis factor (TNF)-α contributes to many physiological and pathological processes and plays an important role in mediating survival signaling and apoptosis. On TNF-α binding, TNF receptor 1 (TNFR1) undergoes a conformational change to form TNFR complex I containing TNFR1-associated death domain (TRADD), receptor-interacting protein (RIP)1 and TNF receptor-associated factor 2 (TRAF2). RIP1 K63 ubiquitination by cellular inhibitor of apoptosis 1/2 (cIAP1/2) or TRAF2 can recruit transforming growth factor-β-activated kinase 1 (TAK1) to initiate the canonical NF-κB survival pathway [8, 9] . On the other hand, upon inhibition of NF-κB signaling, for example, by K63 de-ubiquitination of RIP1 through deubiquitinase or loss of cIAPs, complex II containing TRADD, Fas-associated death domain (FADD), caspase 8 and RIP1 is formed and executes apoptosis which is triggered by caspase 8 [8] . Thus, the state of RIP1 K63 ubiquitination is a switch of TNF-α signaling pathway to determine the cell fate: survival or death [10] .
Indole-3-carbinol (I3C), a naturally occurring compound generated from the hydrolysis of glucobrassicin, is found at exceptionally high concentrations in Brassica vegetables [11] . It has shown that I3C exerts a variety of beneficial effects which include anti-cancer [12] , anti-microbial [13] , immunomodulatory [14] , and anti-inflammatory properties [15] . In our previous study, we have demonstrated that I3C protected liver slices from acetaldehydeinduced HSC activation [16] . In addition, it reversed liver fibrosis in rats induced by compound (CCl 4 , ethanol and lipid) [17] or immunologic (porcine serum) factors [18] in vivo. Furthermore, we proved that I3C remarkably inhibited the proliferation of HSC in vitro [19] . Given the tight relationship with HSC apoptosis and reversion of liver fibrosis, we then aimed to elucidate the effect of I3C on the apoptosis of HSC and the underlying mechanism. In this study, we showed that I3C significantly induced the apoptosis of HSC in vitro, and the inhibition of RIP1 K63 ubiquitination was involved in the mechanism.
Materials and Methods
Chemicals and Reagents I3C, dimethyl sulfoxide (DMSO), and L-glutamine were purchased from Sigma (St. Louis, MO, USA). Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were provided by Invitrogen (Carlsbad, CA, USA). TRIzolR reagent was purchased from Life technologies (Carlsbad, CA, USA Cell culture HSC-T6, an immortalized rat liver stellate cell line, was purchased from Procell Life Science Co., Ltd (Wuhan, China). Cells were maintained at 37 °C, 5 % CO 2 /air in high glucose DMEM supplemented with either 10 % (v/v) FBS, penicillin (100 units/ml), streptomycin (100 μg/ml), 2 mM L-glutamine. After 70% of confluency, the cells were cultured with high glucose DMEM without FBS for 12 hours before the further treatment. For apoptosis analysis, HSC-T6 cells were treated for 24 hours with 25, 50 and 100 μM of I3C, which was dissolved in 0.1%DMSO in media. 
Flow cytometry analysis of apoptosis
Acridine orange cytochemistry staining
The cells were seeded in 24-well dishes containing 1 mL culture medium. After 24 hours incubation of different doses of I3C, The cells were washed twice by PBS, then fixed by 95% alcohol for 10 minutes, and stained by 0.01% acridine orange for 5 minutes [20] . Morphological change was observed by an inverted fluorescence microscope (Olympus, Tokoyo, Japan).
Real-time quantitative PCR
After the treatment of I3C in 6-well plates, Total RNA was extracted using TRIzol ® reagent according to the manufacturer's instructions. One μg RNA was treated with gDNA Eraser and reverse transcribed to cDNA according to the protocol of the PrimScript ® RT reagent kit. Q-PCR was performed on an ABI Step One RT-PCR thermal cycler (ABI Stepone, NY, USA) using SYBR ® Premix Ex Taq™ kit. The housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), was used as a quantitative control. The Ct value of fluorescent product was detected at the extension period and the expression of target genes was analyzed by applying the 2 -ΔΔCt relative quantifcation method. The mRNA expression levels of the target genes were normalized to GAPDH values, and then presented as fold values relative to control group. Primers and annealing temperatures of q-PCR were listed in Table 1 .
Western blot
After the treatment of I3C with different doses for 24 hours in 6-well plates, cells were trypsinized and collected. Protein was extracted using RIPA buffer [50 mM Tris-HCl (PH 7.4), 150 mM NaCl, 1% NP-40, 0.1% SDS]. Homogenates were centrifuged at 4°C for 10 minutes at 14,000 g, the supernatants aliquots were collected. Protein concentrations were determined using a protein assay kit. Aliquots of lysate were mixed -20) containing 5% dry milk for 60 minutes at room temperature, followed by overnight incubation at 4°C with 1:1000 diluted primary antibodies of anti-rat cIAP1, anti-rat cIAP2, antirat TRAF2, anti-rat A20, anti-rat CYLD or anti-rat GAPDH. After 1 hour of incubation with HRP-conjugated secondary antibody (1:5000 dilution), the signal was detected using ECL reagents (Pierce, Cramlington, UK). To compare the relative densities of target proteins among the groups, samples were normalized to GAPDH values, and then presented as fold values relative to control group.
Immunoprecipitation
After the treatment of 100 μM of I3C for 24 hours in 75 cm flasks, the cells were harvested and washed with PBS and then lysed in RIPA buffer on ice for 1 hour. The supernatants were collected and adjusted to the same concentration after centrifugation at 17000 g for 15 minutes. A 2% input sample was set aside, and either primary antibody of RIP1 (8 μL) or normal immunoglobulin antibody was added to 150 μL cell lysates and rotated overnight at 4°C. Subsequently, 25 μL protein A+G agarose beads were added to the mixture and rotated at 4°C for 3 h. The target protein and its complex were collected at 4000 rpm for 5 minutes at 4°C and washed three times with RIPA buffer. Immunoprecipitated proteins were separated in a 10% SDS-PAGE and transferred to nitrocellulose membrane. Membranes were blocked with 5% dry milk in TBST and incubated with 1:1000 diluted primary antibody of anti-rat K63 ubiquitin. Specific signals were revealed by the ECL detection reagent.
siRNA knockdown of CYLD gene
To knockdown CYLD expression, RNA interference technology was used. The sequences of the CYLD siRNA were GGACCUUUAUUAGCGGAGATT and UCUCCGCUAAUAAAGGUCCTT. A pair of non-specific oligonucleotides (nonsilencing control) was used as a negative control; the sequences of the control siRNA were UUCUCCGAACGUGUCACGUTT and ACGUGACACGUUCGGAGAATT. Prior to transfection, HSC-T6 was seeded in six-well plates at a density of 4 × 10 5 cells per well. Twenty-four hours later, cells were then transfected with 30 nM CYLD siRNA or control oligonucleotides using Lipofectamine 3000 in Opti-MEM according to the manufacturer's protocol. The medium was exchanged for a fresh medium after 6 hours, and then the cells were treated with 100 μM I3C. The mRNA of the cells was harvested after 24 hours. Statistics SPSS 17.0 (SPSS Science Inc., Chicago, Illinois) was used for data analysis. For the quantification of data, each assay was repeated at least 3 times independently. All presented measurement data was expressed as the mean ± S.E.M. and was evaluated with one-way ANOVA followed by a post hoc Dunnett-t-test for comparison among multiple groups. Statistical significance was set at P< 0.05.
Results
I3C induces apoptosis of HSC-T6 cells
In order to determine the effect of I3C on apoptosis of HSC-T6, first, we evaluated the apoptotic rate by flow cytometric analysis with Annexin V-FITC/ PI staining. As shown in Fig.  1A , cells were gated into lower right (LR) and upper right (UR) quadrants, which represented early (Annexin V(+)/PI(−)) and late apoptotic (Annexin V(+)/PI(+)) cells, respectively. Cells in lower left (LL) quadrants were considered to be alive and those in the upper left (UL) quadrants were considered to be necrotic. The extent of apoptosis was expressed as the sum total of the percentages in LR and UR quadrants. As in the panel e of Fig. 1A , the apoptosis rate was increased dose-dependently by 48.8%, 100.5% (P<0.05) and 124.0% (P<0.05) in 25, 50 and 100 μM I3C treated groups, respectively, when compared with the control. Next, we detected the morphological change of the apoptotic cells using acridine orange staining, which is a nucleic acid selective metachromatic dye that differentially stains single-stranded nucleic acids orange and double-stranded nucleic acids green [21] . As shown in Fig. 1B, Fig. 1 . Effects of I3C on apoptosis of HSC-T6 cells. A: HSCs apoptosis was determined by Annexin V/PI staining and analyzed by flow cytometry. Mean ± S.E.M. n = 6. B: HSC-T6 cells were stained by acridine orange. (magnification ×200, bar = 50 μm) C: mRNA expression of Bax (a), bcl-2 (b) and the ratio of Bax/bcl-2 (c) in HSC-T6 cells were determined by q-PCR. The samples were normalized to GAPDH values, and then presented as fold values relative to control group. Mean ± S.E.M., n = 6. D: Protein expression of caspase 8 in HSC-T6 cells were determined by western blot. The samples were normalized to GAPDH values, and then presented as fold values relative to control group. Mean ± S.E.M., n = 6. P value was calculated by one-way ANOVA followed by a post hoc Dunnett-t-test. *P <0.05, **P <0.01 vs control. Cells were lysed and endogenous RIP1 was pulled-down and the presence of ubiquitin was detected by western blot using antibodies specifically designed against K63 ubiquitin chains.
I3C inhibits K63 ubiquitination of RIP1
Our previous study found that I3C inhibited the protein expression of NF-κB pathway in HSC-T6 cells [22] . Since NF-κB pathway was activated by K63-ubiquitinated RIP1 [23, 24] , In order to identify whether the inhibitory effect of I3C on NF-κB was due to modification of RIP1 ubiquitination status, we investigated K63-ubiquitination level of RIP1 in HSC-T6 cells. The results revealed that endogenous RIP1 was modified with K63 ubiquitin chains in control group, however, I3C treatment removed most of these ubiquitin chains (Fig. 2) , which indicated that I3C could reduce RIP1 K63-ubiquitinated station in HSC-T6 cells.
I3C induces the expression of deubiquitinases CYLD
RIP1 K63 ubiquitination is regulated by ubiquitin ligases as well as deubiquitinases [23, 24] . In order to explore the mechanism of I3C on the modification of RIP1 K63 ubiquitinated state, we assayed the protein expression of ubiquitin ligases cIAP1, cIAP2, TRAF2 and deubiquitinases CYLD, A20. As shown in Fig. 3 , no significant change was observed on the expression of cIAP1, cIAP2, TRAF2 or A20 among the groups (Fig. 3A-D) , whereas CYLD protein level was increased by 109.5% (P<0.01), 133.0% (P<0.01) and 208.4% (P<0.01) in I3C treated groups when compared with control (Fig.3E) . These results indicated that I3C could induce the expression of CYLD, which might be involved in the mechanism of I3C for modification of RIP1 K63-ubiquitination. Fig. 3 . Effect of I3C on the protein expression of RIP1 ubiquitination regulating enzymes. The cells were treated with of 100 μM of I3C for 24 hours in 6-well plates. A-E: Protein expression of cIAP1 (A), cIAP2 (B), TRAF2 (C), A20 (D) and CYLD (E) in HSC-T6 cells was determined by western blot. The samples were normalized to GAPDH values, and then presented as fold values relative to control group. Mean ± S.E.M., n = 6. P value was calculated by one-way ANOVA followed by a post hoc Dunnett-t-test. *P <0.05, **P <0.01 vs control.
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CYLD silencing inhibits the apoptosis of HSC-T6
In order to prove the involvement of CYLD on pro-apoptotic effect of I3C, we investigate the effect of CYLD silencing on the apoptosis of HSC-T6. As shown in Fig. 4A , the protein expression of CYLD was silenced after knockdown by siRNA (panel a), the induction effect of I3C on its gene expression was also reduced dramatically (panel b). Acridine orange staining showed that CYLD silencing reduced the apoptotic cells induced by I3C (Fig. 4B) . In addition, knockdown of CYLD reversed the inhibition effect of I3C on bcl-2 gene expression as well as the induction on the ratio of Bax/ bcl-2 (Fig. 4C ). All these results suggested that CYLD silencing could abolish the pro-apoptotic effect of I3C in HSC-T6.
Discussion
Proliferation and activation of HSCs is a key step in the development of liver fibrosis [25] [26] [27] . It is reported that the extracellular signal-regulated kinases (ERK)/mitogen-activated protein kinase (MAPK) signaling pathway is involved in the proliferation of HSCs and the . The samples were normalized to GAPDH values, and then presented as fold values relative to control group. Mean ± S.E.M., n = 6. B: CYLD silenced cells were treated with 100 μM of I3C for 24 hours. Cell apoptosis was determined by acridine orange staining. (magnification ×200, , bar = 50 μm) C: mRNA expression of Bax (a), bcl-2 (b) and the ratio of Bax/bcl-2 (c) in HSC-T6 cells was determined by q-PCR. The samples were normalized to GAPDH values, and then presented as fold values relative to control group. Mean ± S.E.M., n = 6. P value was calculated by one-way ANOVA followed by a post hoc Dunnett-t-test.
ECM synthesis in activated HSCs [26, 27] . Our previous study has indicated that I3C could inhibit the proliferation of HSC by blocking the NADPH oxidase/reactive oxygen species/ p38 MAPK signal pathway, which contributes to protective effect of I3C to liver fibrosis in rats [19] . Moreover, in our previous research in vivo, we also proved that I3C could reverse rat liver fibrosis in different models [17, 18] , but the molecular mechanism remains unclear. Given that apoptosis of the activated HSC is the central event of the reversal of hepatic fibrosis [3] [4] [5] [6] , we speculated that I3C could also induce apoptosis of activated HSC. Thus, in this study, we investigated the effect of I3C on the apoptosis of HSC-T6 cells by the assays of flow cytometry analysis, acridine orange cytochemistry staining and expression of apoptotic regulating genes. As expected, all these results strongly suggested that I3C could significantly induce apoptosis of HSC.
TNF-α signaling pathway is an important death receptor-mediated extrinsic apoptosis pathway [28] , which exerts both anti-apoptotic and pro-apoptotic effects [29] . After binding to TNF-R1, on one hand, TNF-α activates NF-κB pathway and inhibits apoptosis; on the other hand, when NF-κB pathway is inactivated, it stimulates FADD and caspase 8 and promotes apoptosis [29] . In our previous study, the results of protein array analysis have indicated that I3C inhibited the protein expression of NF-κB pathway [22] . In this research, we found that I3C induced the protein expression of caspase 8. Therefore, these results suggested that the inhibition to NF-κB pathway and the stimulation to caspase 8 might be involved in the proapoptotic effect of I3C.
In TNF-α signaling pathway, RIP1 is at the upstream of NF-κB, its K63 ubiquitination state acts as a cell-death switch in response to TNF signaling [30] . K63 ubiquitinated RIP1 initiates NF-κB survival pathway, whereas de-ubiquitinated RIP1 is able to stimulate caspase 8 to trigger apoptosis. In the present study, we analyzed the K63 ubiquitination level in different groups, and the results indicated that I3C could inhibit RIP1 K63 ubiquitination state, which might be one of the mechanisms to repress NF-κB pathway and consequently trigger the expression of caspase 8 and apoptosis of HSC.
The K63 ubiquitination of RIP1 is mediated by ubiquitin ligases. TRAF2 serves as an adapter protein and recruits cIAP1 and 2 to the TNF-R1 signalosome, which then target RIP1 directly for polyubiquitination [31] . cIAP 1 and 2 are inhibitor of apoptosis protein family members, they show particularly strong structural homology and function as E3 ligases to mediate RIP1 K63 polyubiquitination [32] . However, in our study, I3C had no influence on the expressions of cIAP1/2 or TRAF2, which suggested that ubiquitin ligases might not be involved in repressive effect on RIP1 K63 ubiquitination by I3C. Like phosphorylation, ubiquitination is a reversible reaction being mediated by deubiquitinases. A20 and CYLD are two major de-ubiquitinating proteases that function in TNF-α signaling pathway [33, 34] . A20 is a bi-functional enzyme that acts on RIP1 both as an ubiquitin protease for K63-linked ubiquitin chains and as an ubiquitin ligase that attaches K48 ubiquitinlinked chains, which promotes the degradation of RIP1 [35, 36] . CYLD was identified as a de-ubiquitinating protease that targets RIP1 and releases its K63-linked ubiquitin chains, thereby decreases the stability of NF-κB pathway as well as enhances cell death by promoting the formation of caspase 8 [37] . In our study, although I3C did not change the expression of A20, it stimulated the protein expression of CYLD in a dose-dependent manner, which suggested that the induction of CYLD contributes to the inhibition to RIP1 K63 ubiquitination by I3C. To further confirm this hypothesis, we knocked down CYLD in HSC-T6 cells to investigate the influence to the pro-apoptotic effect of I3C. Indeed, CYLD silencing inhibited apoptosis of HSC-T6 cells with the evidence of reduced apoptotic cells as well as increased expression ratio of Bax/ bcl-2. Thus, these results indicated that I3C inhibited RIP1 K63 ubiquitination and induced apoptosis of HSC-T6 cells through, at least partly, induction of CYLD.
Taken together, for the first time, the present study demonstrated that I3C could induce apoptosis of HSC through inhibition to RIP1 K63 ubiquitination. In brief, I3C upregulates CYLD expression, thereby degrades K63 ubiquitination of RIP1. Consequently, it inhibits NF-κB pathway and promotes caspase 8-triggered apoptosis in HSC. Thus, together with our previous study in vivo, we have proved that I3C could reverse liver fibrosis through inducing Li et 
